Hikma appoints Henriette NielsenHikma Pharmaceuticals PLC announces the appointment of Henriette Nielsen to the newly created role of Chief Transformation Officer. more ➔
Sygnature Discovery appoints Dr Bill Mar...Sygnature Discovery, thas appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the company’s international growth plans. more ➔
Bavarian Nordic to appoint Henrik Juuel...Bavarian Nordic A/S today announced the appointment of Henrik Juuel to the position of Executive Vice President and Chief Financial Officer. Mr. Juuel is currently the CFO of Orexo AB. more ➔
Rainer Boehm joins Nordic Nanovector Boa...Nordic Nanovector ASA today announces that Rainer Boehm, MD was elected as a member of its Board of Directors at the company’s Annual General Meeting on 30 May 2018. more ➔
Nouscom Appoints Adrian Woolfson as CMONouscom, an immuno-oncology company developing off-the-shelf and personalized neoantigen-based genetic cancer vaccines, announced today the appointment of Adrian Woolfson M.D., Ph.D. as Chief Medical … more ➔
Aldevron Names Marc Wolff CFOMarc Wolff has been named Chief Financial Officer of Aldevron, a provider of plasmid DNA manufacturing, protein production and antibody discovery services. Mr. Wolff will lead the global finance and … more ➔
Horizon Discovery appoints Terry Pizzie...Horizon Discovery Group plc has announced the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. more ➔
Bayer announces new Crop Science Leaders...Bayer today announced the selection of the new Executive Leadership Team for the Crop Science division, which will go into effect as of the closing of Bayer’s proposed acquisition of Monsanto. The closing … more ➔
Sonde Health Adds Thai Lee to Board of D...Sonde Health Inc., an affiliate of PureTech Health (PureTech Health plc, PRTC.L) developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, today … more ➔
Neurimmune Appoints Fabian Buller as CBONeurimmune today announced that it has appointed Dr. Fabian Buller to the newly created position Chief Business Officer. Dr. Buller joins Neurimmune’s executive team and brings 8 years of professional … more ➔
